Astragaloside and/or Hydroxysafflor Yellow A Attenuates Oxygen-Glucose Deprivation-Induced Cultured Brain Microvessel Endothelial Cell Death through Downregulation of PHLPP-1

Astragaloside and/or Hydroxysafflor Yellow A Attenuates Oxygen-Glucose Deprivation-Induced Cultured Brain Microvessel Endothelial Cell Death through Downregulation of PHLPP-1

The incidence of ischemic stroke, a life-threatening condition in humans, amongst Asians is high and the prognosis is poor. In the absence of effective therapeutics, traditional Chinese medicines have been used that have shown promising results. It is crucial to identify traditional Chinese medicine...

Full description

Bibliographic Details
Main Authors:	Jinyi Cao, Kai Wang, Lu Lei, Lu Bai, Ruimin Liang, Yi Qiao, Jialin Duan, Kai Gao, Shanshan Cao, Chao Zhao, Zhifu Yang
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2020/3597527

Similar Items

Establishment of Fluorescence Sensitization Method for Hydroxysafflor Yellow A
by: CAO Haiyan, et al.
Published: (2020-01-01)

Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
by: Naping Hu, et al.
Published: (2016-01-01)

Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
by: Xue Bai, et al.
Published: (2020-09-01)

Hydroxysafflor Yellow A Shows Protection against PPARγ Inactivation in Nitrosative Neurons
by: Li Sun, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A (HSYA) Improves Learning and Memory in Cerebral Ischemia Reperfusion-Injured Rats via Recovering Synaptic Plasticity in the Hippocampus
by: Lu Yu, et al.
Published: (2018-10-01)

Hydroxysafflor Yellow A Attenuates Hydrogen Peroxide-Induced Oxidative Damage on Human Umbilical Vein Endothelial Cells
by: Yuefeng Xie, et al.
Published: (2020-01-01)

Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism
by: Weiling Pu, et al.
Published: (2017-12-01)

Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs
by: Xingtao Wang, et al.
Published: (2016-04-01)

The effects of hydroxysafflor yellow A on PPARγ expression in glutamate⁃induced neuron damage
by: Xing⁃miao LIU, et al.
Published: (2012-06-01)

Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases
by: Hui Ao, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits
by: Shan Le-qun, et al.
Published: (2010-08-01)

Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer
by: Na Wu, et al.
Published: (2021-04-01)

Hydroxysafflor Yellow A Attenuates the Apoptosis of Peripheral Blood CD4+ T Lymphocytes in a Murine Model of Sepsis
by: Jinping Wang, et al.
Published: (2017-09-01)

Hydroxysafflor Yellow A (HSYA) from Flowers of Carthamus tinctorius L. and Its Vasodilatation Effects on Pulmonary Artery
by: Lijun Wu, et al.
Published: (2012-12-01)

Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis
by: Jingxue Ye, et al.
Published: (2021-01-01)

Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
by: Xin-Tong Wang, et al.
Published: (2021-04-01)

Chondrocytic and pharmacokinetic properties of Phlpp inhibitors
by: E.L. Taylor, et al.
Published: (2021-09-01)

Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
by: Jieyu Zhou, et al.
Published: (2015-01-01)

Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis
by: Si-Qian Gao, et al.
Published: (2018-01-01)

Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation
by: Jingyu Zhang, et al.
Published: (2019-01-01)

Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat
by: Maosheng Lee, et al.
Published: (2020-01-01)

Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2020-07-01)

Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury
by: Teng Li, et al.
Published: (2021-01-01)

Hydroxysafflor Yellow A Exerts Anti-Inflammatory Effects Mediated by SIRT1 in Lipopolysaccharide-Induced Microglia Activation
by: Xiude Qin, et al.
Published: (2020-09-01)

Hydroxysafflor Yellow A Suppresses Platelet Activating Factor-Induced Activation of Human Small Airway Epithelial Cells
by: Xinjing Guo, et al.
Published: (2018-08-01)

Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis
by: Li Liu, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A Alleviates Ovalbumin-Induced Asthma in a Guinea Pig Model by Attenuateing the Expression of Inflammatory Cytokines and Signal Transduction
by: Meng Zheng, et al.
Published: (2019-04-01)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach
by: Cheng Qu, et al.
Published: (2016-11-01)

Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2021-04-01)

MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells
by: Tang D, et al.
Published: (2021-04-01)

Enhanced Neutrophil Immune Homeostasis Due to Deletion of PHLPP
by: Taojing Ran, et al.
Published: (2019-09-01)

Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
by: Yijia Fangma, et al.
Published: (2021-09-01)

Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways
by: Xiaomei Yang, et al.
Published: (2020-01-01)

Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects
by: Feng Zhao, et al.
Published: (2020-12-01)

Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A.
by: Zhu Jin, et al.
Published: (2013-01-01)

Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies
by: Lv Q, et al.
Published: (2012-07-01)

Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology
by: Yangyang Zhang, et al.
Published: (2020-03-01)

Pharmacological Studies on Astragalosides
by: Lee-Shih-Yu, et al.
Published: (2004)

PHLPP1 counter-regulates STAT1-mediated inflammatory signaling
by: Ksenya Cohen Katsenelson, et al.
Published: (2019-08-01)